Commodity
HIGHTrigger: demand supply imbalance persists, exerting short-term price pressures
Monitor: commodity
Jubilant Ingrevia Ltd: Why Is It Outperforming Nifty 500?
ActiveRS +22.4%Weak
In , Jubilant Ingrevia Ltd (Pesticides/Agrochemicals) is outperforming Nifty 500 with +22.4% relative strength. Fundamentals: Weak.
Jubilant Ingrevia Ltd Key Facts
- PE Ratio
- 43.0x
- Market Cap
- ₹11,828 Cr
- PAT Growth YoY
- -32%
- Revenue Growth YoY
- -1%
- OPM
- 12.0%
- RS vs Nifty 500
- +22.4%
PE: Mid ContractionStrong Opportunity
What's Happening
💎PE falling while earnings hold — value emerging
👔Promoter stake down 6.3% this quarter
🌐FII stake decreased 1.3% this quarter
🏛️DII accumulation — stake up 7.6%
Key Risks
1. Commodity
HIGH2. Fx
LOW3. Regulatory
LOWKey Numbers
PAT Growth YoY
-32%
Inflection Down
Revenue YoY
-1%
Stable
Operating Margin
12.0%
-100 bps YoY
PE Ratio
43.0
Current Price
₹743
Dividend Yield
0.67%
Fundamental Score
30/100
Weak
3Y PAT CAGR
-19%
Market Cap
11.8K Cr
Valuation
N/A12-Week Performance
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
12 weeks agoThis week
What Are the Key Risks for Jubilant Ingrevia Ltd?
Earnings deceleration risks from management commentary
Fx
LOWTrigger: we also import a lot of raw materials, particularly on our acetyls business
Monitor: fx
Regulatory
LOWTrigger: mandated by the New Labour Code amendments
Monitor: regulatory
What Is Jubilant Ingrevia Ltd's Management Saying?
Key quotes from recent conference calls
“EBITDA for quarter stood at INR136 crore, reflecting an 8% year-on-year decline, primarily due to lower pricing across most segments. [Risk (commodity): HIGH]”
“we have a natural hedge within the P&L. So at the overall company level, we are by and large agnostic to the rupee movement. [Risk (fx): LOW]”
“The adjustment of INR13 crore was recorded under the exceptional items and primarily related to provisioning of employee gratuity and leave encashment [Risk (regulatory): LOW]”
How Fast Is Jubilant Ingrevia Ltd Growing?
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | -1% | -5% | Stable |
| PAT (Net Profit) | -32% | -19% | Inflection Down |
| OPM | 12.0% | -100 bps | Stable |
The above analysis is parsed from publicly available earnings call transcripts. This is educational research only — not investment advice. Last updated Apr 30, 2026.
Other Top Pesticides/Agrochemicals Stocks Beating Nifty 500
Frequently Asked Questions: Jubilant Ingrevia Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What were Jubilant Ingrevia Ltd's latest quarterly results?
Jubilant Ingrevia Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: -31.9% (inflecting downward)
- Revenue Growth YoY: -0.6%
- Operating Margin: 12.0% (stable)
Is Jubilant Ingrevia Ltd's profit growing or declining?
Jubilant Ingrevia Ltd's profit is declining with an inflecting downward trend.
- PAT Growth YoY: -31.9% (latest quarter)
- PAT Growth QoQ: -31.9% (sequential)
- 3-Year PAT CAGR: -19.3%
- Trend: Inflecting downward — consistent growth pattern
What is Jubilant Ingrevia Ltd's revenue growth trend?
Jubilant Ingrevia Ltd's revenue growth trend is stable.
- Revenue Growth YoY: -0.6%
- Revenue Growth QoQ: -6.2% (sequential)
- 3-Year Revenue CAGR: -5.5%
How is Jubilant Ingrevia Ltd's operating margin trending?
Jubilant Ingrevia Ltd's operating margin is stable.
- Current OPM: 12.0%
- OPM Change YoY: -1.0% basis points
- OPM Change QoQ: 0.0% basis points
What is Jubilant Ingrevia Ltd's 3-year profit and revenue CAGR?
Jubilant Ingrevia Ltd's long-term compounding rates
- 3-Year Profit CAGR: -19.3%
- 3-Year Revenue CAGR: -5.5%
Is Jubilant Ingrevia Ltd's growth accelerating or decelerating?
Jubilant Ingrevia Ltd's earnings growth is inflecting downward with weakening on a sequential basis.
- YoY Acceleration: -48.8% bps
- Sequential Acceleration: -23.9% bps
What is Jubilant Ingrevia Ltd's trailing twelve month (TTM) performance?
Jubilant Ingrevia Ltd's trailing twelve month (TTM) performance
- TTM PAT: ₹265 Cr
- TTM PAT Growth: +28.6% YoY
- TTM Revenue: ₹4,000 Cr
- TTM Revenue Growth: +1.4% YoY
- TTM Operating Margin: 13.0%
What is Jubilant Ingrevia Ltd's current PE ratio?
Jubilant Ingrevia Ltd's current PE ratio is 43.0x.
- Current PE: 43.0x
- Market Cap: 11.8K Cr
- Dividend Yield: 0.67%
What is Jubilant Ingrevia Ltd's price-to-book ratio?
Jubilant Ingrevia Ltd's price-to-book ratio is 3.9x.
- Price-to-Book (P/B): 3.9x
- Book Value per Share: ₹191
- Current Price: ₹743
Is Jubilant Ingrevia Ltd a fundamentally strong company?
Jubilant Ingrevia Ltd is rated Weak with a fundamental score of 30/100. This score is calculated from objective financial metrics
- Revenue Growth YoY: -0.6% (10% weight)
- PAT Growth YoY: -31.9% (10% weight)
- PAT Growth QoQ: -31.9% (10% weight)
- Margins stable (10% weight)
Is Jubilant Ingrevia Ltd debt free?
Jubilant Ingrevia Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹764 Cr
What is Jubilant Ingrevia Ltd's return on equity (ROE) and ROCE?
Jubilant Ingrevia Ltd's return ratios over recent years
- FY2023: ROCE 16.0%
- FY2024: ROCE 10.0%
- FY2025: ROCE 11.0%
Is Jubilant Ingrevia Ltd's cash flow positive?
Jubilant Ingrevia Ltd's operating cash flow is positive (FY2025).
- Cash from Operations (CFO): ₹508 Cr
- Free Cash Flow (FCF): ₹119 Cr
- CFO/PAT Ratio: 202% (strong cash conversion)
What is Jubilant Ingrevia Ltd's dividend yield?
Jubilant Ingrevia Ltd's current dividend yield is 0.67%.
- Dividend Yield: 0.67%
- Current Price: ₹743
Who holds Jubilant Ingrevia Ltd shares — promoters, FII, DII?
Jubilant Ingrevia Ltd's shareholding pattern (Mar 2026)
- Promoters: 45.2%
- FII (Foreign): 6.5%
- DII (Domestic): 24.8%
- Public: 22.5%
Is promoter holding increasing or decreasing in Jubilant Ingrevia Ltd?
Jubilant Ingrevia Ltd's promoter holding has remained stable recently.
- Current Promoter Holding: 45.2% (Mar 2026)
- Previous Quarter: 45.2% (Dec 2025)
- Change: 0.00% (stable)
How long has Jubilant Ingrevia Ltd been outperforming Nifty 500?
Jubilant Ingrevia Ltd has been outperforming Nifty 500 for 3 consecutive weeks, indicating early-stage outperformance.
Is Jubilant Ingrevia Ltd a new momentum entry or an established outperformer?
Jubilant Ingrevia Ltd is an established outperformer with 3 weeks of consecutive Nifty 500 outperformance.
What are the key risks in Jubilant Ingrevia Ltd?
Jubilant Ingrevia Ltd has 3 key risks worth monitoring
- [HIGH] Commodity — demand supply imbalance persists, exerting short-term price pressures
- [LOW] Fx — we also import a lot of raw materials, particularly on our acetyls business
- [LOW] Regulatory — mandated by the New Labour Code amendments
What did Jubilant Ingrevia Ltd's management say in the latest earnings call?
In Q3 FY26, Jubilant Ingrevia Ltd's management highlighted
- "EBITDA for quarter stood at INR136 crore, reflecting an 8% year-on-year decline, primarily due to lower pricing across most segments. [Risk (commodit..."
- "we have a natural hedge within the P&L. So at the overall company level, we are by and large agnostic to the rupee movement. [Risk (fx): LOW]"
- "The adjustment of INR13 crore was recorded under the exceptional items and primarily related to provisioning of employee gratuity and leave encashment..."
Is Jubilant Ingrevia Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Jubilant Ingrevia Ltd may be worth studying
- Cash flow is positive — CFO ₹508 Cr
What is the investment thesis for Jubilant Ingrevia Ltd?
Jubilant Ingrevia Ltd investment thesis summary:
Risk Factors (Bear Case)
- Key risk: Commodity
What is the future outlook for Jubilant Ingrevia Ltd?
Jubilant Ingrevia Ltd's forward outlook based on current data signals
- Earnings Trend: inflecting downward
- Revenue Trend: stable
- Margin Trend: stable
- Key Risk: Commodity
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.